These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22542036)

  • 21. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
    Singh N
    Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
    J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytomegalovirus infection in transplant recipients].
    Gondo H
    Nihon Rinsho; 1998 Jan; 56(1):173-8. PubMed ID: 9465685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA
    Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus in solid organ transplant recipients.
    Humar A; Snydman D;
    Am J Transplant; 2009 Dec; 9 Suppl 4():S78-86. PubMed ID: 20070700
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quick diagnosis of cytomegalovirus infection].
    Lautenschlager I
    Duodecim; 1990; 106(13):979-83. PubMed ID: 1670342
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of real-time PCR and pp65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone marrow transplants.
    Marchetti S; Santangelo R; Manzara S; D'onghia S; Fadda G; Cattani P
    New Microbiol; 2011 Apr; 34(2):157-64. PubMed ID: 21617827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in understanding cytomegalovirus infection after transplantation.
    Ho M
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):7-11. PubMed ID: 7940978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of cytomegalovirus disease in outcome of solid organ transplant patients.
    Linares L; Sanclemente G; Cervera C; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Marcos MA; Antón A; Pumarola T; Moreno A
    Transplant Proc; 2011; 43(6):2145-8. PubMed ID: 21839217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection in solid-organ transplant recipients.
    Fishman JA
    N Engl J Med; 2007 Dec; 357(25):2601-14. PubMed ID: 18094380
    [No Abstract]   [Full Text] [Related]  

  • 31. Cadaver donor screening for infectious agents in solid organ transplantation.
    Delmonico FL
    Clin Infect Dis; 2000 Sep; 31(3):781-6. PubMed ID: 11017830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation.
    Stratta RJ
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):15-21. PubMed ID: 8212302
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.
    Razonable RR; Paya CV; Smith TF
    J Clin Microbiol; 2002 Mar; 40(3):746-52. PubMed ID: 11880387
    [No Abstract]   [Full Text] [Related]  

  • 35. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Pescovitz MD
    Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
    Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Snydman DR; Allen U; Humar A;
    Transplantation; 2010 Apr; 89(7):779-95. PubMed ID: 20224515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

  • 39. Extrapulmonary cytomegalovirus disease in transplant patients.
    Petersen EA
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):13-6. PubMed ID: 1647557
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing the economic merits of managing cytomegalovirus infection in organ and stem cell transplantation.
    Wait S; Musingarimi P; Briggs A; Tillotson G
    J Med Econ; 2009 Mar; 12(1):68-76. PubMed ID: 19450067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.